Related Experiment Video
Updated: Nov 6, 2025

Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface
Miguel Ángel Muñoz-Alía1, Rebecca A Nace1, Lianwen Zhang1
1Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Abstract:
After centuries of pestilence and decades of global vaccination, measles virus (MeV) genotypes capable of evading vaccine-induced immunity have not emerged. Here, by systematically building mutations into the hemagglutinin (H) glycoprotein of an attenuated measles virus strain and assaying for serum neutralization, we show that virus evolution is severely constrained by the existence of numerous co-dominant H glycoprotein antigenic sites, some critical for binding to the pathogenicity receptors SLAMF1 and nectin-4. We further demonstrate the existence in serum of protective neutralizing antibodies targeting co-dominant fusion (F) glycoprotein epitopes. Lack of a substantial reduction in serum neutralization of mutant measles viruses that retain even one of the co-dominant antigenic sites makes evolution of pathogenic measles viruses capable of escaping serum neutralization in vaccinated individuals extremely unlikely.
Insights
Measles virus (MeV) evolution is limited by its hemagglutinin glycoprotein's numerous antigenic sites, preventing immune escape. This suggests measles virus cannot easily evade vaccine-induced immunity.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Measles virus (MeV) remains a global health concern despite widespread vaccination efforts.
- The emergence of MeV genotypes capable of evading vaccine-induced immunity has not been observed.
- Understanding the evolutionary constraints on MeV is crucial for predicting its future behavior.
Purpose of the Study:
- To investigate the evolutionary constraints on measles virus (MeV) hemagglutinin (H) glycoprotein.
- To determine the impact of mutations on MeV's ability to evade serum neutralization.
- To assess the likelihood of MeV evolving to escape vaccine-induced immunity.
Main Methods:
- Systematic introduction of mutations into the H glycoprotein of an attenuated MeV strain.
- Assaying serum neutralization of mutant MeV strains.
- Analyzing the role of co-dominant antigenic sites on the H glycoprotein.
- Identifying critical binding sites for SLAMF1 and nectin-4 receptors.
Main Results:
- The MeV H glycoprotein possesses numerous co-dominant antigenic sites that severely constrain virus evolution.
- Some antigenic sites are critical for binding to the SLAMF1 and nectin-4 receptors.
- Protective neutralizing antibodies in serum target co-dominant fusion (F) glycoprotein epitopes.
- Mutant MeV viruses retaining even one co-dominant antigenic site showed minimal reduction in serum neutralization.
Conclusions:
- The extensive network of co-dominant antigenic sites on the MeV H and F glycoproteins significantly limits its evolutionary potential.
- The inability of MeV to readily evolve escape mutants suggests a low likelihood of pathogenic measles virus emerging that can evade vaccine-induced immunity.
- Current vaccination strategies remain robust against measles virus immune escape.
Related Concept Videos
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Cross-reactivity

